Letter from Japan

Respirology. 2021 Feb;26(2):206-207. doi: 10.1111/resp.13986. Epub 2020 Dec 2.

Author

Keiko Kan-O^{1

2}

Affiliations

¹ Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Endoscopic Diagnostics and Therapeutics, Kyushu University Hospital, Fukuoka, Japan.

No abstract available

Keywords: COVID-19; Japan; SARS-CoV-2.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Chemokine CCL17
Humans
Japan / epidemiology
SARS-CoV-2

Substances

CCL17 protein, human
Chemokine CCL17